Funded by the NIH HEAL Initiative®
This study will examine whether 1) in hospitals with addiction medicine consultation services, hospital-initiated extended release buprenorphine (XR-BUP), compared to other OUD medications, results in increased OUD treatment engagement following hospital discharge; and 2) training hospitals without such consultation services on best practices for initiating OUD medication using consultation service hubs improves medication uptake in hospitals and following discharge.
CTN Protocol ID:
CTN-0098
Status:
Active
ClinicalTrials.gov ID:
Principal Investigator(s)
Gavin Bart, M.D., Ph.D., FACP, FASAM
Director, Addiction Medicine
Minneapolis Medical Research Foundation
Hennepin County Medical Center
701 Park Avenue G5
Minneapolis, MN 55415
United States
Richard Saitz, MD, MPH, FACP, DFASAM
Chair, Department of Community Health Sciences
Boston University School of Public Health
801 Massachusetts Ave., 4th Floor
Boston, MA 02118
United States